Download Novartis at AACR Annual Meeting - Novartis Institutes for BioMedical

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Published on Novartis Institutes for BioMedical Research (https://www.nibr.com)
Home > Printer-friendly PDF > Novartis at AACR Annual Meeting
Novartis at AACR Annual Meeting
Novartis-AARC-header2
We’re excited to share some of our scientific progress at the American Association for Cancer
Research (AACR) Annual Meeting. This meeting unites our researchers with colleagues from
around the world, providing an ideal forum for discussing research advances that could
potentially benefit cancer patients.
This temporary web page highlights a selection of our researchers’ presentations, recent
stories about their work, and resources to inform visitors about our Oncology and Immunooncology groups. (For full meeting details, visit the AACR 2016 home page [1].)
Select NIBR Calendar Highlights at AACR
Related Novartis Content
Precision Oncology Index Image
Immuno-o
index imag
Oncology disease area [2]
Immuno-oncolo
area [3]
Pancreatic_cancer_cells_Ann_Weston_LRI_CRUK_small HelaCell -
Intractable tumor cells crippled [5]
Novartis and Pf
to upend oncolo
precision-medicine - image
Cancer Sp
drug-Imag
Novartis cancer researchers advance precision medicine [8]
Cancer spies fi
beating covert c
Football image small
Molecular
Scissors -
Researchers aim to beat trick play by tumors with drug combo [11]
Can we edit ou
disease? [12]
Tab: Saturday 4/16
[14]
Time
Title
Speaker
5:30 PM - 6:30 PM
Tenth Annual AACR Award for Outstanding
Jay Bradner
Achievement in Chemistry in Cancer Research Jay
Bradner Chemical biology & chromatin remodeling [15]
Sunday 4/17
[16]
Time
Title
Speaker
10:00 AM - 10:30 AM
Targeting epigenomic dependencies in cancer [17] Jay Bradner
5:35 PM - 5:50 PM
In vivo activity of a novel CDH6 targeting antibody-
Carl U. Bialucha , J
drug conjugate, including population-scale ovarian
Williams, Emma Le
PDX clinical trial [18]
al.
Time
Title
Speaker
2:10 PM - 2:35 PM
Dual inhibition of the Abelson kinase in CML
suppresses resistant clonal evolution [20] Bill Sellers
Monday 4/18
[19]
8:00 AM - 12:00 PM
High order drug combinations are required to
Giordano Caponigr
effectively kill colorectal cancer cells [21]
(Google, Dana-Far
session list)
Tuesday 4/19
[22]
Time
Title
Speaker
11:40 AM - 12:05 PM
Disordered methionine metabolism in MTAP/CDKN2A
Bill Sellers
deleted cancers leads to dependence on PRMT5 [23]
5:00 PM - 6:30 PM
Wednesday 4/20
Genotype Versus Phenotype for Patient Selection [24]
Bill Sellers
[25]
Time
Title
Speaker
10:55 AM - 11:20 AM
Direct activation of STING in the tumor
John Tallarico microenvironment leads to potent and systemic tumor
regression and immunity [26]
Source URL: https://www.nibr.com/news/events/novartis-aacr-annual-meeting
Links
[1] http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=63#.VxDvHeYrJZq
[2] https://www.nibr.com/our-research/disease-areas/oncology
[3] https://www.nibr.com/our-research/disease-areas/immuno-oncology
[4] https://www.nibr.com/stories/nerd-blog/crispr-genome-editing-fuels-cancer-drug-discovery
[5] https://www.nibr.com/stories/nerd-blog/intractable-tumor-cells-crippled
[6] https://www.nibr.com/stories/nerd-blog/novartis-and-pfizer-join-forces-upend-oncology-dogma
[7] https://www.nibr.com/stories/nerd-blog/clinical-trials-make-move-toward-mice
[8] https://www.nibr.com/stories/discovery/novartis-cancer-researchers-advance-precision-medicine
[9] https://www.nibr.com/stories/nerd-blog/cancer-spies-find-drug-beating-covert-cells
[10] https://www.nibr.com/stories/discovery/rallying-troops-immune-system-fight-cancer
[11] https://www.nibr.com/stories/nerd-blog/researchers-aim-beat-trick-play-tumors-drug-combo
[12] https://www.nibr.com/stories/discovery/can-we-edit-our-genes-fight-disease
[13] https://www.nibr.com/stories/discovery/boost-immunotherapy
[14] https://www.nibr.com/news/events/novartis-aacr-annual-meeting#tab-1
[15] http://www.abstractsonline.com/Plan/ViewSession.aspx?mID=1668&sKey=1ee001a8-00bc-47f58fe7-51208a4ab8b4&mKey=%7b1D10D749-4B6A-4AB3-BCD4-F80FB1922267%7d
[16] https://www.nibr.com/news/events/novartis-aacr-annual-meeting#tab-2
[17] http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=65fce26e-2fd2-47d59593-711d4ba4c1e2&cKey=05c2486a-41ba-4840-b5be-ff4fee3404d0&mKey=1d10d749-4b6a4ab3-bcd4-f80fb1922267
[18] http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=dcc60d03-0069-4777-9e45-
dc3234c8c972&cKey=1d23bd79-fd8d-461e-8ff5-3ef1326fb134&mKey=%7b1D10D749-4B6A4AB3-BCD4-F80FB1922267%7d
[19] https://www.nibr.com/news/events/novartis-aacr-annual-meeting#tab-3
[20] http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=c4729656-58de4032-ae18-c782431a2d7b&cKey=3a2d1f08-c48f-4f9f-82d5-1a25e0ecb741&mKey=1d10d7494b6a-4ab3-bcd4-f80fb1922267
[21] http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=a6522824-42a9-40e4-b4bdecbf064dd41e&cKey=717f50e2-bcec-4876-8623-f756ff5afd87&mKey=1d10d749-4b6a-4ab3bcd4-f80fb1922267
[22] https://www.nibr.com/news/events/novartis-aacr-annual-meeting#tab-4
[23] http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=edab683a-7d8a4edc-aaf3-776659cb252c&cKey=53578c1c-80f9-46db-be88-6f0f10a1cb7d&mKey=1d10d7494b6a-4ab3-bcd4-f80fb1922267
[24] http://www.abstractsonline.com/Plan/ViewSession.aspx?mID=1668&sKey=f15cd347-1ea8-45ff86d7-441d2117f1d5&mKey=1d10d749-4b6a-4ab3-bcd4-f80fb1922267
[25] https://www.nibr.com/news/events/novartis-aacr-annual-meeting#tab-5
[26] http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=402b707f-0e76-45a0a2f1-baa4f5ee1f45&cKey=2a103f1f-14a3-4c95-965f-91441cded236&mKey=1d10d749-4b6a4ab3-bcd4-f80fb1922267